Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide-Reference-Cited by-同舟云学术

Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide

Published:2017-03 Issue:3 Volume:19 Page:e2942
ISSN:1099-498X
Container-title:The Journal of Gene Medicine
language:en
Short-container-title:J Gene Med

Author:

Jaime-Ramirez Alena Cristina¹,Dmitrieva Nina¹,Yoo Ji Young¹,Banasavadi-Siddegowda Yeshavanth¹,Zhang Jianying²,Relation Theresa³,Bolyard Chelsea¹,Wojton Jeffrey¹,Kaur Balveen¹

Affiliation:

1. Department of Neurological Surgery; The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital, and Solove Research Institute; Columbus OH USA

2. Center for Biostatistics Biomedical Informatics Department; The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital, and Solove Research Institute; Columbus OH USA

3. Neuroscience Graduate Program and The Medical Scientist Training Program; The Ohio State University Comprehensive Cancer Center, The James Cancer Hospital, and Solove Research Institute; Columbus OH USA

Funder

National Institutes of Health

Pelotonia Post Doctoral Fellowship (ACJR)

American Cancer Society

Publisher

Wiley

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Reference38 articles.

1. Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: a population-based analysis;Johnson;Cancer,2013

2. From barriers to bridges: chondroitin sulfate proteoglycans in neuropathology;Viapiano;Trends Mol Med,2006

3. Proteoglycans and their roles in brain cancer;Wade;FEBS J,2013